Explore All 2734 Add-on Acquisition Medical Products Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | January 4, 2010 |
| Target | BioForm Medical |
| Sector | Medical Products |
| Buyer(s) | Merz Pharma & Co. KGaA |
| Sellers(s) | EW Healthcare Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 253M USD |
| Advisor(s) | J.P. Morgan Securities (Financial) Dewey & LeBoeuf LLP Ropes & Gray (Legal) |
FILTER BY
| Category | Company |
|---|---|
| Sector | Life Science |
| Revenue | 980M USD (2012) |
Merz Pharma GmbH & Co. KGaA combines the activities of its three subsidiaries, namely Merz Pharmaceuticals, Merz Consumer Care, and Merz Dental.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 6 |
| Sector: Medical Products | 1 of 2 |
| Type: Add-on Acquisition | 1 of 5 |
| State: California | 1 of 2 |
| Country: United States | 1 of 4 |
| Year: 2010 | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-07-19 |
Lasya - Intellectual Property Assets
Carrboro, North Carolina, United States Lasya, Inc. - Intellectual Property Assets includes both U.S. and international patent filings of deoxyArbutin. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1985 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.
| Deal Context for Seller | # |
|---|---|
| Overall | 16 of 54 |
| Sector: Medical Products | 7 of 25 |
| Type: Add-on Acquisition | 9 of 35 |
| State: California | 6 of 18 |
| Country: United States | 14 of 47 |
| Year: 2010 | 1 of 7 |
| Size (of disclosed) | 10 of 22 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-12-15 |
Molecular Partners
Schlieren, Switzerland Molecular Partners is a clinical-stage biotech company developing DARP in therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. Molecular Partners was founded in 2004 and is headquartered in Schlieren, Switzerland. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-01-06 |
InSound Medical
Newark, California, United States InSound Medical is a developer and manufacturer of hearing devices. |
Sell | $75M |
